Literature DB >> 18725826

Implications of new colorectal cancer screening technologies for primary care practice.

Ann G Zauber1, Theodore R Levin, C Carl Jaffe, Barbara A Galen, David F Ransohoff, Martin L Brown.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18725826      PMCID： PMC4854519          DOI： 10.1097/MLR.0b013e31818192ef

Source DB:  PubMed          Journal:  Med Care        ISSN： 0025-7079            Impact factor:   2.983


× No keyword cloud information.
  64 in total

1.  A widely applicable protocol for DNA isolation from fecal samples.

Authors:  Bao-Wei Zhang; Ming Li; Li-Chao Ma; Fu-Wen Wei
Journal:  Biochem Genet       Date:  2006-12       Impact factor: 1.890

Review 2.  Computed tomography--an increasing source of radiation exposure.

Authors:  David J Brenner; Eric J Hall
Journal:  N Engl J Med       Date:  2007-11-29       Impact factor: 91.245

3.  Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps.

Authors:  Wai K Leung; Ka-Fai To; Ellen P S Man; Michael W Y Chan; Aric J Hui; Simon S M Ng; James Y W Lau; Joseph J Y Sung
Journal:  Am J Gastroenterol       Date:  2007-03-22       Impact factor: 10.864

Review 4.  Molecular basis for stool-based DNA tests for colorectal cancer: a primer for clinicians.

Authors:  C Richard Boland
Journal:  Rev Gastroenterol Disord       Date:  2002

5.  Detecting colorectal cancer in stool with the use of multiple genetic targets.

Authors:  S M Dong; G Traverso; C Johnson; L Geng; R Favis; K Boynton; K Hibi; S N Goodman; M D'Allessio; P Paty; S R Hamilton; D Sidransky; F Barany; B Levin; A Shuber; K W Kinzler; B Vogelstein; J Jen
Journal:  J Natl Cancer Inst       Date:  2001-06-06       Impact factor: 13.506

Review 6.  Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society.

Authors:  Sidney J Winawer; Ann G Zauber; Robert H Fletcher; Jonathon S Stillman; Michael J O'Brien; Bernard Levin; Robert A Smith; David A Lieberman; Randall W Burt; Theodore R Levin; John H Bond; Durado Brooks; Tim Byers; Neil Hyman; Lynne Kirk; Alan Thorson; Clifford Simmang; David Johnson; Douglas K Rex
Journal:  Gastroenterology       Date:  2006-05       Impact factor: 22.682

7.  A quantitative immunochemical fecal occult blood test for colorectal neoplasia.

Authors:  Zohar Levi; Paul Rozen; Rachel Hazazi; Alex Vilkin; Amal Waked; Eran Maoz; Shlomo Birkenfeld; Moshe Leshno; Yaron Niv
Journal:  Ann Intern Med       Date:  2007-02-20       Impact factor: 25.391

8.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.

Authors:  J D Hardcastle; J O Chamberlain; M H Robinson; S M Moss; S S Amar; T W Balfour; P D James; C M Mangham
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

9.  Colorectal cancer in African Americans.

Authors:  Sangeeta Agrawal; Anand Bhupinderjit; Manoop S Bhutani; Lisa Boardman; Cuong Nguyen; Yvonne Romero; Radhika Srinivasan; Radhika Srinvasan; Colmar Figueroa-Moseley
Journal:  Am J Gastroenterol       Date:  2005-03       Impact factor: 10.864

10.  Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.

Authors:  James E Allison; Lori C Sakoda; Theodore R Levin; Jo P Tucker; Irene S Tekawa; Thomas Cuff; Mary Pat Pauly; Lyle Shlager; Albert M Palitz; Wei K Zhao; J Sanford Schwartz; David F Ransohoff; Joseph V Selby
Journal:  J Natl Cancer Inst       Date:  2007-09-25       Impact factor: 13.506
View more
  5 in total

1.  Comparing 3 values clarification methods for colorectal cancer screening decision-making: a randomized trial in the US and Australia.

Authors:  Alison Brenner; Kirsten Howard; Carmen Lewis; Stacey Sheridan; Trisha Crutchfield; Sarah Hawley; Dan Reuland; Christine Kistler; Michael Pignone
Journal:  J Gen Intern Med       Date:  2013-11-23       Impact factor: 5.128

Review 2.  Australia's national bowel cancer screening program: does it work for indigenous Australians?

Authors:  Aliki Christou; Judith M Katzenellenbogen; Sandra C Thompson
Journal:  BMC Public Health       Date:  2010-06-25       Impact factor: 3.295

3.  Cost-effectiveness of a multitarget stool DNA test for colorectal cancer screening of Medicare beneficiaries.

Authors:  Steffie K Naber; Amy B Knudsen; Ann G Zauber; Carolyn M Rutter; Sara E Fischer; Chester J Pabiniak; Brittany Soto; Karen M Kuntz; Iris Lansdorp-Vogelaar
Journal:  PLoS One       Date:  2019-09-04       Impact factor: 3.240

4.  Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states.

Authors:  Aaron L Sarver; Amy J French; Pedro M Borralho; Venugopal Thayanithy; Ann L Oberg; Kevin A T Silverstein; Bruce W Morlan; Shaun M Riska; Lisa A Boardman; Julie M Cunningham; Subbaya Subramanian; Liang Wang; Tom C Smyrk; Cecilia M P Rodrigues; Stephen N Thibodeau; Clifford J Steer
Journal:  BMC Cancer       Date:  2009-11-18       Impact factor: 4.430

5.  Colorectal cancer screening in an equal access healthcare system.

Authors:  Mia Debarros; Scott R Steele
Journal:  J Cancer       Date:  2013-03-20       Impact factor: 4.207
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.